Latest Manufacturing News

PARKD has inked a pivotal five-year exclusive licensing agreement with Fielders, a BlueScope Steel division, to commercialise its innovative MDSB® and MDSS® products in Australia and explore international expansion.

Sparc Technologies has secured a fourth trial agreement with BHP Mitsubishi Alliance to test its graphene-enhanced ecosparc® coating in harsh mining conditions, aiming to validate its anti-corrosive performance against market leaders.

AdAlta Limited is accelerating its 'East to West' cellular immunotherapy strategy, aiming to bridge Asian innovation with Western clinical development and manufacturing to target solid cancers. The company plans to secure three assets by the end of 2025 and initiate clinical trials, positioning itself as a leader in this emerging market.

Tempest Minerals has signed a Memorandum of Understanding with Green Steel and Iron to develop a $3 billion hot briquette iron processing hub near its Yalgoo Project, aiming to supply high-grade magnetite for green steelmaking.

News Corporation reported a robust half-year performance with revenues up 4% to $4.33 billion and net income soaring 80% to $334 million, while advancing its strategic pivot through the planned sale of Foxtel.

Northern Minerals has completed the second tranche of its placement, raising $41.5 million to advance its Browns Range Heavy Rare Earth Project, focusing on the high-grade Wolverine deposit.

Micro-X Ltd has announced a $6 million capital raising alongside a $2.4 million strategic investment from Billion Prima, underpinning its pivot towards medical imaging and cashflow stability.

Eureka Group Holdings has acquired a mixed-use residential park in Gladstone, marking its strategic entry into the all-age rental market with promising yield and expansion potential.

Resouro Strategic Metals reports outstanding assay results from its Tiros Central Project in Brazil, revealing high-grade titanium dioxide and rare earth elements that underscore the project's global significance.

AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.

The Calmer Co. International Limited has secured a FJD2.64 million loan from Fiji Development Bank to acquire its Navua manufacturing site, marking a strategic step to enhance production and market presence in the global kava industry.

Vitrafy Life Sciences reports strong progress in cryopreservation technology development and US market expansion following a successful $35 million IPO. The company highlights improved biological sample preservation outcomes and strategic commercial milestones.